Discontinuation report MINT-RIVASTIGMINE

Last updated on 2017-07-01
Report ID 13565
Drug Identification Number 02407000
Brand name MINT-RIVASTIGMINE
Common or Proper name Rivastigmine
Company Name MINT PHARMACEUTICALS INC
Active Ingredient(s) RIVASTIGMINE
Strength(s) 4.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size Blister pack of 56 Capsules.
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-06-30
Remaining supply date 2017-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 1093 MEYERSIDE DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 1J6
Company contact information